Use the balance sheet and income statement below. VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of...

Transcribed Image Text:

Use the balance sheet and income statement below. VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars). Current assets: Assets Cash and marketable securities Accounts receivable Inventory Total Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets 2024 2023 Liabilities and Equity 2024 2823 Current liabilities: $87 205 $ 86 Accrued wages and taxes 5.64 $56 196 Accounts payable 162 156 321 306 Notes payable 146 146 $613 $ 588 Total $372 $ 358 Long-term debt 5 648 $586 $ 1,118 176 $942 128 $784 164 164 $ 1,106 $948 $ 1,719 Total $ 912 Stockholders' equity: Preferred stock (6 thousand shares) Common stock and paid-in surplus (100 thousand shares) Retained earnings $1,536 Total liabilities and equity VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 $6 56 120 120 573 466 $ 699 $592 $1,719 $1,536 (in millions of dollars) 2024 2023 Net sales $922 $832 Gross profits Less: Cost of goods sold Less: Other operating expenses Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) $ $18 62 $456 $ 408 63 $345 72 $273 404 367 $465 56 $ 409 48 46 $363 57 $ 306 64 $242 $6 $267 $6 $236 160 $107 160 $76 $2.67 $ 2.36 $1.60 $1.60 $6.93 $ 5.86 $7.96 $6.34 Prepare a statement of cash flows for Valium's Medical Supply Corporation. Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. Statement of Cash Flows for Year Ending December 31, 2024 Use the balance sheet and income statement below. VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars). Current assets: Assets Cash and marketable securities Accounts receivable Inventory Total Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets 2024 2023 Liabilities and Equity 2024 2823 Current liabilities: $87 205 $ 86 Accrued wages and taxes 5.64 $56 196 Accounts payable 162 156 321 306 Notes payable 146 146 $613 $ 588 Total $372 $ 358 Long-term debt 5 648 $586 $ 1,118 176 $942 128 $784 164 164 $ 1,106 $948 $ 1,719 Total $ 912 Stockholders' equity: Preferred stock (6 thousand shares) Common stock and paid-in surplus (100 thousand shares) Retained earnings $1,536 Total liabilities and equity VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 $6 56 120 120 573 466 $ 699 $592 $1,719 $1,536 (in millions of dollars) 2024 2023 Net sales $922 $832 Gross profits Less: Cost of goods sold Less: Other operating expenses Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) $ $18 62 $456 $ 408 63 $345 72 $273 404 367 $465 56 $ 409 48 46 $363 57 $ 306 64 $242 $6 $267 $6 $236 160 $107 160 $76 $2.67 $ 2.36 $1.60 $1.60 $6.93 $ 5.86 $7.96 $6.34 Prepare a statement of cash flows for Valium's Medical Supply Corporation. Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. Statement of Cash Flows for Year Ending December 31, 2024